Detalles de la búsqueda
1.
Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.
Circulation
; 149(7): 498-509, 2024 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37961906
2.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342789
3.
Monitoring treatment with cardiac myosin inhibitors in symptomatic obstructive hypertrophic cardiomyopathy.
Curr Opin Cardiol
; 38(5): 424-432, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382090
4.
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 396(10253): 759-769, 2020 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32871100
5.
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
JAMA
; 325(1): 39-49, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33275134
6.
Influenza Vaccine in Heart Failure.
Circulation
; 139(5): 575-586, 2019 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30586760
7.
Progression of Cardiac Abnormalities in Hutchinson-Gilford Progeria Syndrome: A Prospective Longitudinal Study.
Circulation
; 147(23): 1782-1784, 2023 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276254
8.
Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study.
Circulation
; 137(20): 2142-2151, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29386202
9.
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
Circulation
; 136(11): 982-992, 2017 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28637881
10.
Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study.
Eur Heart J
; 37(32): 2544-51, 2016 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27071820
11.
Influence of Physical Activity on Hypertension and Cardiac Structure and Function.
Curr Hypertens Rep
; 17(10): 77, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26277725
12.
Long-Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER-OLE Study.
J Am Heart Assoc
; 13(8): e030607, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38591260
13.
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease: A Secondary Analysis of the INVESTED Randomized Clinical Trial.
JAMA Cardiol
; 2024 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583091
14.
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort.
JACC Heart Fail
; 12(1): 164-177, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38176782
15.
Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome.
Front Cardiovasc Med
; 11: 1356010, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38725831
16.
Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
Eur J Heart Fail
; 25(2): 260-270, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404399
17.
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(9): e2331284, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37707817
18.
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial.
Eur J Heart Fail
; 25(2): 299-310, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335639
19.
A multicenter program for electronic health record screening for patients with heart failure with preserved ejection fraction: Lessons from the DELIVER-EHR initiative.
Contemp Clin Trials
; 121: 106924, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100197
20.
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial.
JAMA Cardiol
; 7(12): 1259-1263, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190011